{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:29:42Z","timestamp":1784798982696,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771752"],"award-info":[{"award-number":["81771752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370881"],"award-info":[{"award-number":["31370881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31570902"],"award-info":[{"award-number":["31570902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91742113"],"award-info":[{"award-number":["91742113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370894"],"award-info":[{"award-number":["32370894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949102"],"award-info":[{"award-number":["91949102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0107500"],"award-info":[{"award-number":["2018YFA0107500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ymthe.2025.01.048","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:09:54Z","timestamp":1738670994000},"page":"1519-1534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of RelB-targeting small-molecule inhibitors of non-canonical NF-\u03baB signaling with antitumor efficacy"],"prefix":"10.1016","volume":"33","author":[{"given":"Cuifeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deji","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4080-433X","authenticated-orcid":false,"given":"Xiaoren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.01.048_bib1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.167.3.1592","article-title":"Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment","volume":"167","author":"Alcamo","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.048_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.048_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.01.048_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.01.048_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-kappaB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.01.048_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2016.03.002","article-title":"Noncanonical NF-kappaB Signaling in Health and Disease","volume":"22","author":"Cildir","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.01.048_bib10","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1074\/jbc.M800806200","article-title":"Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression","volume":"283","author":"Wang","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib11","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1172\/JCI68901","article-title":"NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-kappaB","volume":"124","author":"Zhang","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.048_bib12","first-page":"31","article-title":"NFkappaB2 (p52) promoter activation via Notch signaling pathway in rheumatoid synoviocytes","volume":"7","author":"Nakazawa","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.01.048_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.celrep.2015.03.059","article-title":"An oncogenic role for alternative NF-kappaB signaling in DLBCL revealed upon deregulated BCL6 expression","volume":"11","author":"Zhang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.01.048_bib14","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1073\/pnas.0308016101","article-title":"Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP)","volume":"101","author":"Matta","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.048_bib15","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/sj.onc.1207120","article-title":"Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma\/NEMO-independent signalling pathway","volume":"22","author":"Eliopoulos","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.01.048_bib16","doi-asserted-by":"crossref","first-page":"31770","DOI":"10.1016\/S0021-9258(19)84092-9","article-title":"Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2\/BCL3 complex through kappaB site of cyclin D1 promoter","volume":"281","author":"Park","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18632\/oncotarget.109","article-title":"A critical role for the NFkB pathway in multiple myeloma","volume":"1","author":"Demchenko","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.01.048_bib18","first-page":"2839","article-title":"Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies","volume":"8","author":"Fracchiolla","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.01.048_bib19","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1128\/MCB.15.9.5180","article-title":"Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators","volume":"15","author":"Chang","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib20","first-page":"2335","article-title":"Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells","volume":"9","author":"Thakur","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.01.048_bib21","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.01.048_bib22","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1073\/pnas.0509808103","article-title":"Stat3 activation of NF-kappaB p100 processing involves CBP\/p300-mediated acetylation","volume":"103","author":"Nadiminty","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.048_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.309","article-title":"RelB\/NF-kappaB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis","volume":"7","author":"Ge","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.01.048_bib24","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1038\/s41388-018-0363-4","article-title":"Alternative NF-kappaB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3","volume":"37","author":"Tao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.01.048_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Moreau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.01.048_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1078-0432.CCR-04-1936","article-title":"Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor","volume":"11","author":"Sanda","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.01.048_bib27","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1074\/jbc.M209677200","article-title":"BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice","volume":"278","author":"Burke","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","article-title":"NF-kappaB-inducing kinase maintains T\u00a0cell metabolic fitness in antitumor immunity","volume":"22","author":"Gu","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2025.01.048_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bcp.2006.08.007","article-title":"The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development","volume":"72","author":"Dejardin","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.01.048_bib32","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.048_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls","volume":"8","author":"Baud","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.01.048_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jcb.20080","article-title":"Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target","volume":"92","author":"Monks","year":"2004","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drup.2004.01.003","article-title":"NF-kappaB in cancer--a friend turned foe","volume":"7","author":"Ravi","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ymthe.2025.01.048_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1074\/jbc.M109619200","article-title":"RelB cellular regulation and transcriptional activity are regulated by p100","volume":"277","author":"Solan","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib37","doi-asserted-by":"crossref","first-page":"e1646","DOI":"10.1002\/wsbm.1646","article-title":"The noncanonical NFkappaB pathway: Regulatory mechanisms in health and disease","volume":"16","author":"Rodriguez","year":"2024","journal-title":"Wires Mech. Dis."},{"key":"10.1016\/j.ymthe.2025.01.048_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/embor.2008.227","article-title":"NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes","volume":"10","author":"Fusco","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2025.01.048_bib39","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1039\/c2ob07104e","article-title":"Involvement of DNA binding domain in the cellular stability and importin affinity of NF-kappaB component RelB","volume":"10","author":"Takeiri","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.048_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-020-0138-6","article-title":"Bcl-3 promotes Wnt signaling by maintaining the acetylation of beta-catenin at lysine 49 in colorectal cancer","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.01.048_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2009.12.043","article-title":"Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence","volume":"17","author":"Reimann","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:41:48Z","timestamp":1762548108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525001625000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.048","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of RelB-targeting small-molecule inhibitors of non-canonical NF-\u03baB signaling with antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}